Marksans Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue grew significantly by 21% in the latest quarter compared to the same quarter last year, indicating strong demand.
Net profit reached an all-time high of ₹105.07 Cr, showing effective cost management and increased sales.
Operating profit margin improved, reflecting better operational efficiency and pricing strategy over the last few quarters.

NEGATIVES

Profit dropped by 10% in the latest quarter compared to the previous quarter, raising concerns about future profitability.
Other income fluctuated heavily, causing uncertainty in total income streams for the company.
High depreciation costs have persisted, impacting net profit margins despite increased revenues.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	531.24	586.13	560.01	590.62	641.92	681.85	708.46	619.99
Expenses	436.46	478.27	476.27	485.55	528.38	566.44	608.88	549.03
Operating Profit	94.77	107.86	83.75	105.07	113.54	115.41	99.58	70.96
Other Income	19	4.80	16.53	14.95	11.06	27.85	16.52	5.64
Interest	1.63	3.16	4.84	2.92	2.63	2.67	3.44	6.06
Depreciation	17.55	22	21.05	20.44	19.51	20.69	22.74	23.10
Profit Before Tax	113.77	112.66	100.28	120.02	124.60	143.26	116.09	76.60
Tax	29.92	29.69	22.63	30.95	26.84	38.19	25.37	18.40
Net Profit	83.85	82.97	77.64	89.07	97.76	105.07	90.73	58.20
Eps in Rs	1.84	1.84	1.73	1.96	2.13	2.31	2	1.29